The top 100 stock
market authors
selected for publication
market authors
selected for publication
ISIS Pharmaceuticals, Inc. (ISIS) ()
|
|
|
| 52wk high: | |
| 52wk low: | |
| EPS: | |
| PE: | |
| Dividend: | |
| Yield: | |
| Market Cap: | |
| Exchange: |
Articles on ISIS Pharmaceuticals, Inc. (ISIS) by latest | most commented
- Isis Generating Impressive Oncology, Diabetes Data
- ADA Meeting 2009: Novel Diabetes Therapies Presented
- FDA, Clinical Trial Updates: Heart Stents, Cholesterol in the News
- Isis, Genzyme May Have a Winning Drug
- FDA, Clinical Trial Calendar Updates: WYE, SVNT, AMRN, ISIS, SLXP, SOMX
- FDA, Clinical Trial Calendar Updates: Genzyme, Isis, Osiris, Roche, Watson
- Business Trends: Coke and Pepsi, Genzyme, Mortgage Bankers, Autos, Health Insurance
- Where Might Genentech Investors Redeploy $47B?
- 20 Emerging Healthcare Stocks to Watch in '09
- Hedge Fund Tracking: Farallon Capital Management (Thomas Steyer), Q3 2008
- 40 Top Rated Emerging Bio-Pharma Stocks
- Expecting Isis Stock to Rise on Abbott Purchase
- Can MicroRNA Reverse Heart Disease?
- Isis Technology Used to Attack Brain Tumors
- Pfizer Needs Isis More Than Isis Needs Pfizer
- Even Fatter Yields for Pfizer; M&A Targets in the Sector
- 'When There's Blood in the Streets', Buy Biotech Stocks
- Biotech Names With Big Potential
- Isis Pharmaceuticals' Obesity Buster an Enormous Finding
- In Tech We Trust - Fast Money Recap (6/20/08)
- FDA Stings Pharma, Big and Small
- Investing in miRNA: Beware the Hype, Follow the Money
- Fast Money Recap - Oil Spoils Everything (6/6/08)
- Three Game-Changers For Big Pharma
- Six Significant Gene Therapy Stocks
- Isis Pharmaceuticals Panic Overdone
- Rosetta Genomics: Mining Genes From Junk (Part II)
- Fast Money Recap, 4/1/08: Gold Takes the Elevator
- Isis-Genzyme: Deal of the Year?
- ISIS Pharma Should Jump on 'Multiple Catalysts'
- A Volatile January for Financials, Healthcare
- Wal-Mart's Guidance Shows No Sign of Slow-Down, Good for Investors
- Pharma, Biotech Present Great Investment Opportunities in 2008
- A Win-Win for Isis, Genzyme in Cholesterol Drug Deal
- Tuesday's Options Report: CFC, Starbucks, ISIS, CVS, BUD, DFS
- VMware, Isis Pharma: Avoid Emotion in Market Swings
- A Bark Worse Than Its Bite
- Gaming Rules For Trading Biotech Stocks
- Differentiating Between Stocks and the Stock Market
- Companies With The Most Analyst Attention & Affection
- Biotech Day In Review: Regeneron Up On AMD Data
-
The Seeking Alpha 100
See all
Seeking Alpha 100 » -
Fastest Climbers
Authors with the largest
increase in followers
in the last 7 days-
1
David Fry
-
2
Bill Gross
-
3
TraderMark
-
4
Peter Schiff
-
5
Serge Hagopian
Fastest Climbers » -
1
-
Top Commenters
Top commenters,See all
as ranked by their peers
Top Commenters » -
Top Instabloggers
The 100 most activeSee all
Instabloggers.
Top Instabloggers » -
Top StockTalkers
TopSee all
StockTalkers.
Top StockTalkers »
